Mesoporous polymeric nanoparticles for effective treatment of inflammatory diseases: an in vivo study
Divya Pareek,
No information about this author
Md. Zeyaullah,
No information about this author
Sukanya Patra
No information about this author
et al.
Journal of Materials Chemistry B,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Glycine-based
polymer
nanoparticles
for
the
treatment
of
inflammatory
diseases
without
using
any
additional
drugs.
Language: Английский
Healthcare inequities and healthcare providers: we are part of the problem
International Journal for Equity in Health,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: April 7, 2025
Language: Английский
Berry Fruit Extracts as Topical Cosmeceuticals for Skin Health Applications: A Systematic Review
Cosmetics,
Journal Year:
2025,
Volume and Issue:
12(3), P. 87 - 87
Published: April 23, 2025
Berries
are
a
popular
source
of
natural
bioactive
compounds
with
distinctive
aspects
and
sensory
attributes.
In
this
review,
the
term
“berry”
refers
to
generally
round,
small,
colorful,
juicy
fruits
English
common
names
ending
in
“berry”.
They
have
high
phenolic
content,
which
has
been
linked
their
health-relevant
properties.
To
gather
information
on
potential
berries
for
treating
skin
inflammatory
diseases,
systematic
review
was
conducted
following
PRISMA
guidelines
(PROSPERO
registration
number
CRD
42024549567),
based
studies
from
PubMed,
Scopus,
Web
Science,
Embase.
It
focused
preclinical
murine
model
studies,
bias
methodological
quality
assessed
using
SYRCLE’s
RoB
tool.
Studies
showed
evidence
that
anti-inflammatory
antioxidant
properties
due
like
anthocyanins,
cyanidins,
polyphenols,
catechins.
Berry
exposure
reduced
oxidative
stress
markers,
such
as
malondialdehyde,
carbonylated
proteins,
nitric
oxide,
8-OHdG,
pyrimidine
dimers.
This
reduction
associated
NF-κB
COX-2
pathway
downregulation,
lower
IL-6,
IL-1β,
TNF-α,
MAPK,
increased
IL-10.
Morphological
outcomes
included
collagen,
elastin,
glycosaminoglycans,
proteoglycans
metalloproteinases.
Bias
analysis
revealed
low
risk,
suggesting
reliable
studies.
treatments
improved
wound
healing
extracellular
matrix
(ECM)
production,
supporting
pharmaceutical
topical
formulation.
Language: Английский
Inhibition of MCP1 (CCL2) Enhances Antitumor Activity of NK Cells Against HCC Cells Under Hypoxia
Hwan Hee Lee,
No information about this author
Jaehyun Kim,
No information about this author
Eunbi Park
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(10), P. 4900 - 4900
Published: May 20, 2025
Hypoxia,
a
low-oxygen
state,
is
common
feature
of
solid
tumors.
MCP1
(CCL2)
small
cytokine
that
closely
related
to
hypoxia
and
has
positive
effect
on
tumor
development.
Hypoxia
causes
resistance
various
treatments
for
tumors
the
evasion
cancer
immune
surveillance
by
lymphocytes.
Natural
killer
(NK)
cells
are
innate
lymphocytes
play
an
important
role
in
development,
particularly
liver.
First,
it
was
found
incubation
HCC
(2–5%
O2)
significantly
increased
production
several
inflammatory
cytokines,
including
MCP1,
compared
normal
oxygen
(20%
O2).
Subsequently,
blocking
with
anti-MCP1
antibody
cultures
inhibited
growth
migration
vitro
vivo.
This
associated
decrease
expression
HIF-1α/STAT3
under
hypoxia.
Furthermore,
cell
chemotaxis
activation
NK-92
against
cells.
blockade
induced
shift
NK
CD56+dim
population
increase
receptors
NKG2D
NKp44.
In
conclusion,
modulation
could
enhance
activity
hypoxic
Language: Английский